Cargando…
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside
Atherosclerotic cardiovascular disease is the leading cause of death and a major part of its pathophysiology remains obscure. Some hematological targets have been related to the development and clinical outcome of this disease, especially soluble cytokines, leukocytes, red blood cells, hemostatic fa...
Autores principales: | Villegas, Ana, Gonzalez, Fernando A, Llorente, Leopoldo, Redondo, Santiago |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721378/ https://www.ncbi.nlm.nih.gov/pubmed/19707371 |
Ejemplares similares
-
Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside
por: Kumric, Marko, et al.
Publicado: (2023) -
Micrornas and Cardiovascular Diseases: From Bench to Bedside
por: De Rosa, R., et al.
Publicado: (2018) -
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
por: Feng, Yimei, et al.
Publicado: (2021) -
Mast Cells in Cardiovascular Disease: From Bench to Bedside
por: Hermans, M. A. W., et al.
Publicado: (2019) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)